1. |
刘又宁, 陈民钧, 赵铁梅, 等. 中国城市成人社区获得性肺炎 665 例病原学多中心调查. 中华结核和呼吸杂志, 2006, 29(1): 3-8.
|
2. |
Nick P, Frances PF, Timothy H, et al. Epidemiology and clinical management of Legionnaires' disease. Lancet Infect Dis, 2014, 14(10): 1011-1021.
|
3. |
中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 成人社区获得性肺炎基层诊疗指南(2018年). 中华全科医师杂志, 2019, 18(2): 117-126.
|
4. |
Engel MF, Van ML, Hoepelman AIM, et al. Diagnostic, therapeutic and economic consequences of a positive urinary antigen test for Legionella spp.in patients admitted with community-acquired pneumonia: a 7-year retrospective evaluation. J Clin Pathol,, 2013, 66(9): 797-802.
|
5. |
Francisco A, Claudia PC, Marcelo V, et al. Importance of Legionella pneumophila in the Etiology of Severe Community-Acquired Pneumonia in Santiago, Chile. Chest, 2014, 145(2): 290-296.
|
6. |
Kirschner AKT. Determination of viable legionellae in engineered water systems: Do we find what we are looking for?. Water Res, 2016, 93: 276-288.
|
7. |
Cunha BA, Cunha CB. Legionnaire's disease: a clinical diagnostic approach. Infect Dis Clin North Am, 2017, 31(1): 81-93.
|
8. |
Mandell L, Wunderink R, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guide-lines on the management of community-acquired pneumonia in adults. Clin Infect Dis, 2007, 44(2): S27-S72.
|
9. |
Pierre DM, Baron J, Yu VL, et al. Diagnostic testing for Legionnaires' disease. Ann Clin Microbiol Antimicrob, 2017, 16(1): 59.
|
10. |
Shimada T, Noguchi Y, Jackson JL, et al. Systematic review and metaanalysis: urinary antigen tests for Legionellosis. Chest, 2009, 136(6): 1576-1585.
|
11. |
Jordi C, Carolina GV. An update on Legionella. Curr Opin Infect Dis, 2010, 23(2): 152-157.
|
12. |
Levy ML, Le JI, Woodhead MA, et al. Primary care summary of the British Thoracic Society Guidelines for the management of community acquired pneumonia in adults: 2009 update. Endorsed by the Royal College of General Practitioners and the Primary Care Respiratory Society UK. Prim Care Respir J, 2010, 19(1): 21-27.
|
13. |
Amsden GW. Treatment of Legionnaires’ disease. Drugs, 2005, 65(5): 605-614.
|